Sustainability at AstraZeneca Great place to work Our approach

Source URL: www.astrazeneca.com

КОДЕКС ПОВЕДЕНИЯ Этот перевод связан с английским Кодекс поведения V4.0 (эффективная апрель 2014)

Source URL: www.astrazeneca.com

Candidature for the Scientific Award Foundation AstraZeneca – Cardiovascular/Metabolic Diseases

Source URL: www.fnrs.be

Information on Early Access to AstraZeneca Investigational Medicinal Products Foundational Principles AstraZeneca‘s primary focus is to develop new medicines that make a meaningful difference to patients’ lives.

Source URL: www.astrazeneca.com

Sustainability at AstraZeneca Access to healthcare Our approach

Source URL: www.astrazeneca.com

AstraZeneca Group Global Public Policy Public Policy Issue: Non-Exclusive Voluntary License AstraZeneca will in good faith consider granting a Non-Exclusive Voluntary Licence (NEVL) to any Party wishing to manufacture a

Source URL: www.astrazeneca.com

ASTRAZENECA GLOBAL POLICY SAFEGUARDING COMPANY ASSETS AND RESOURCES THIS POLICY SETS OUT THE REQUIREMENTS FOR SAFEGUARDING COMPANY ASSETS AND RESOURCES

Source URL: www.astrazeneca.com

• Prevention
• Safety
• Security
• Computer security
• Data security
• Auditing
• National security
• Information security
• Internal control
• Risk management
• Audit
• Resilience

Global Standard Expectations of Third Parties

Source URL: www.astrazeneca.com

• Medical research
• Business
• Health
• Food and Drug Administration
• Pharmaceutical industry
• AstraZeneca
• Sdertlje Municipality
• Zeneca
• Clinical trial
• Mediation
• Non-disclosure agreement
• Privacy

aaaaaaaaaaa a
aaaa
aaaaaaa
a
a
aaaaa
aa
aaaa  

Source URL: www.astrazeneca.com

Reasons for CRADA Delays In the Past Ongoing • Sponsors hesitant and not

Source URL: www.vmrf.net

• Business
• Economy
• Biotechnology
• AstraZeneca
• Sdertlje Municipality
• Boehringer Ingelheim
• Sanofi
• Cooperative research and development agreement
• Amgen